Pictor Biotech Unites Innovative Forces in Strategic Acquisition

Deal News | Jan 23, 2025 | PR Newswire Cision Pictor Biotech Inc. (dba SOLARBIOTECH), GPC Bio, and Eleszto Genetika

Pictor Biotech Inc., operating as SOLARBIOTECH, along with partners GPC Bio and Eleszto Genetika, have announced a strategic acquisition and unification under a single ownership, effective on January 23, 2025. This consolidation aims to establish a vertically integrated hub for synthetic biology and biofabrication, leveraging the disruptive potential of precision fermentation. The unified organization encompasses over 100 skilled professionals and is set to support clients through every stage of bioproduction, from strain and bioprocess development to large-scale operations. The unification intends to tackle challenges in microbial strain engineering and bioprocess scale-up, with a view to revolutionize the synthetic biology landscape by offering the necessary operational and financial backing. Leaders from each company will maintain their roles, and a focused effort on integrated development will follow in the coming months. Peter Rosholm, owner and investor in the merger, emphasizes the commitment to sustainable biofabrication and development through this unified effort. SOLARBIOTECH, GPC Bio, and Eleszto Genetika each bring distinct strengths, promising a robust client-focused organization poised for substantial growth in the biofabrication sector.

Sectors

  • Biotechnology
  • Manufacturing
  • Pharmaceuticals

Geography

  • United States – SOLARBIOTECH is based in Norton, Virginia, USA.
  • France – GPC Bio is headquartered in La Rochelle, France.
  • Hungary – Eleszto Genetika operates from Budapest, Hungary.

Industry

  • Biotechnology – The article discusses companies engaged in biotechnological research and development, highlighting advancements in synthetic biology and biofabrication.
  • Manufacturing – The unification includes companies specializing in the manufacturing of biofabrication equipment and processes.
  • Pharmaceuticals – The operations involve production-related activities applicable to the biopharmaceuticals market.

Financials

    Participants

    NameRoleTypeDescription
    Pictor Biotech Inc. (d.b.a. SOLARBIOTECH)TargetCompanyPictor Biotech is a key player in advanced fermentation technologies.
    GPC BioBidding CompanyCompanySpecializes in biotechnology and biofabrication equipment design and manufacturing.
    Eleszto Genetika Kft.Bidding CompanyCompanyFocuses on R&D in microbial strain development.
    Peter RosholmOwner/InvestorPersonInvestor driving the strategic consolidation of the three companies.
    Alex BerlinCEOPersonCEO of Pictor Biotech, spearheading operational and financial initiatives.
    Zsolt PopséCEOPersonCEO of GPC Bio, provides strategic leadership.
    Lóránd SzabóDirector GeneralPersonOversees the scientific and developmental directions at Eleszto Genetika.